BROS is trading at $56.32 (+5.02%) after UBS reiterated its Buy rating and set an $85 price target, citing confidence in long-term sales momentum.

  • Analysts highlighted potential for 2026 growth driven by key initiatives such as the company's upcoming food rollout strategy.
  • The stock is significantly outpacing the broader market rally, which saw the S&P 500 gain 1.00% and the NASDAQ rise 1.54% following a US-Iran ceasefire extension.